1. Home
  2. CXDO vs ANIK Comparison

CXDO vs ANIK Comparison

Compare CXDO & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CXDO

Crexendo Inc.

HOLD

Current Price

$6.62

Market Cap

223.1M

ML Signal

HOLD

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$14.95

Market Cap

200.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXDO
ANIK
Founded
1995
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
223.1M
200.9M
IPO Year
1999
1996

Fundamental Metrics

Financial Performance
Metric
CXDO
ANIK
Price
$6.62
$14.95
Analyst Decision
Strong Buy
Buy
Analyst Count
5
1
Target Price
$9.20
$17.00
AVG Volume (30 Days)
522.0K
59.7K
Earning Date
05-05-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
166.67
80.16
EPS
0.02
N/A
Revenue
$68,167,000.00
$112,819,000.00
Revenue This Year
$45.26
$5.98
Revenue Next Year
$13.31
$7.42
P/E Ratio
$334.50
N/A
Revenue Growth
12.05
N/A
52 Week Low
$5.26
$7.90
52 Week High
$11.23
$16.49

Technical Indicators

Market Signals
Indicator
CXDO
ANIK
Relative Strength Index (RSI) 34.41 46.28
Support Level $6.54 $13.88
Resistance Level $7.02 $15.53
Average True Range (ATR) 0.48 0.65
MACD -0.10 -0.13
Stochastic Oscillator 29.63 17.80

Price Performance

Historical Comparison
CXDO
ANIK

About CXDO Crexendo Inc.

Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: